CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C

World News: . []

ALACHUA Fla Oct 05 2018 GLOBE NEWSWIRE -- CTD LINK  Inc OTCQB CTDH a clinical stage biotechnology company that LINK  cyclodextrin-based products for the treatment of diseasetoday LINK  that it has begun recruiting patient s at At...

More news and information about CTD Holdings, Inc.

Published By:

Globe Newswire: 13:00 GMT Friday 5th October 2018

Published: .

Search for other references to "holdings" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us